Familial non medullary thyroid cancer

European Surgery - Acta Chirurgica Austriaca

Volumn 34, Issue 5, 2002, Pages 292-295

  Clark, O H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Familial non medullary thyroid cancer; Genetic testing; Hereditary thyroid cancer syndromes; Thyroid cancer oxyophilia gene; Total thyroidectomy

Indexed keywords

AUTOSOMAL DOMINANT INHERITANCE; CANCER RISK; CANCER SCREENING; CANCER SUSCEPTIBILITY; CHROMOSOME 19P; FAMILIAL NON MEDULLARY THYROID CANCER; FAMILIAL POLYPOSIS; GENE LOCUS; GENE MUTATION; GENETIC LINKAGE; GENETIC PROCEDURES; GERM LINE; HISTOPATHOLOGY; HUMAN; LYMPHADENOPATHY; ONCOCYTOMA; PATIENT CARE; RADIATION EXPOSURE; REVIEW; THYROID CANCER; THYROIDECTOMY; ULTRASOUND;

EID: 0036965529     PISSN: 16821769     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1563-2563.2002.02076.x     Document Type: Review

References (56)

1. Leprat F, Bonichon F, Guyot M, Trouette H, Trojani M, Vergnot V, Longy M, Belleannee G, de Mascarel A, Roger P: Familial non-medullary thyroid carcinoma: pathology review in 27 affected cases from 13 French families. Clin Endocrinol 1999;50:589-594.
2. Charkes ND: On the prevalence of familial nonmedullary thyroid cancer (letter). Thyroid 1998;8:857-858.
3. Grossman RF, Tu SH, Duh QY, Siperstein AE, Novosolov F, Clark OH: Familial nonmedullary thyroid cancer. An emerging entity that warrants aggressive treatment (see comments). Arch Surg 1995;130:892-897. Discussion, 898-899.
4. Lupoli G, Vitale G, Caraglia M, Fittipaldi MR, Abbruzzese A, Tagliaferro P, Bianco AR: Familial papillary thyroid microcarcinoma: a new clinical entity (see comments). Arch Surg 1999;353:637-639.
5. Burgess JR, Duffield A, Wilkinson S J, Ware R, Greenaway TM, Percival J, Hoffman L: Two families with an autosomal dominant inheritance pattern for papillary carcinoma of the thyroid. J Clin Endocrinol Metab 1997;82:345-348.
6. McKay JD, Williamson J, Lesueur F, Stark M, Duffield A, Canzian F, Romeo G, Hoffman L: At least three genes account for familial papillary thyroid carcinoma: TCO and MNG1 excluded as susceptibility loci from a large Tasmanian family. Eur J Endocrinol 1999;141:122-125.
7. Malchoff CD, Sarfarazi M, Tendler B, Forouhar F, Whalen G, Malchoff DM: Familial papillary thyroid carcinoma is genetically distinct from familial adenomatous polyposis coli. Thyroid 1999;9:247-252.
8. Canzian F, Amati P, Harach HR, Kraimps JL, Lesueur F, Barbier J, Levillain P, Romeo G, Bonneau D: A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2. Am J Hum Genet 1998;63:1743-1748.
9. Malchoff CD, Sarfarazi M, Tendler B, Forouhar F, Whalen G, Joshi V, Arnold A, Malchoff DM: Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome. J Clin Endocrinol Metab 2000;85:1758-1764.
10. Lesueur F, Stark M, Tocco T, Ayadi H, Delisle MJ, Goldgar DE, Schlumberger M, Romeo G, Canzian F: Genetic heterogeneity in familial nonmedullary thyroid carcinoma: exclusion of linkage to RET, MNG1, and TCO in 56 families. NMTC Consortium. J Clin Endocrinol Metab 1999;84:2157-2162.
11. Soravia C, Sugg SL, Berk T, Mitri A, Cheng H, Gallinger S, Cohen Z, Asa SL, Bapat BV: Familial adenomatous polyposis-associated thyroid cancer: a clinical, pathological, and molecular genetics study. Am J Pathol 1999; 154:127-135.
12. Burgess JR, Dwyer T, McArdle K, Tucker P, Shugg D: The changing incidence and spectrum of thyroid carcinoma in Tasmania (1978-1998) during a transition from iodine sufficiency to iodine deficiency. J Clin Endocrinol Metab 2000;85:1513-1517.
13. Harach HR, Lesueur F, Amati P, Brown A, Canzian F, Kraimps JL, Levillin P, Menet E, Romeo G, Bonneau D: Histology of familial thyroid tumours linked to a gene mapping to chromosome 19p13.2. J Pathol 1999;189:387-393.
14. Vriens MR, Sabanci U, Epstein HD, Ngai S, Duh QY, Siperstein AE, Clark OH: Reliability of fine-needle aspiration in patients with familial nonmedullary thyroid cancer. Thyroid 1999;9:1011-1016.
15. Perrier ND, van Heerden JA, Goellner JR, Williams ED, Gharib H, Marchesa P, Church JM, Fazio VW, Larson DR: Thyroid cancer in patients with familial denomatous polyposis. World J Surg 1998;22:738-742. Discussion, 743.
16. Harach HR, Soubeyran I, Brown A, Bonneau D, Longy M: Thyroid pathologic findings in patients with Cowden disease. Ann Diagnost Pathol 1999;3:331-340.
17. Stoffen SS, Van Dyke DL, Bach JV, Szpunar W, Weiss L: Familial papillary thyroid carcinoma of the thyroid. Am J Med Genet 1986;25:775-782.
18. Eng C: Editorial: Familial papillary thyroid cancer-many syndromes, too many genes? J Clin Endocrinol Metab 2000;85:1755-1756.
19. Phay JE, Moley JF, Lairmore TC: Multiple endocrine neoplasias. Semin Surg Oncol 2000,18:324-332.
20. Heptulla RA, Schwartz RP, Bale AE, Flynn S, Genel M: Familial medullary thyroid carcinoma: presymptomatic diagnosis and management in children. J Pediatric 1999,135:327-331.
21. Kebebew E, Ituarte PH, Siperstein AE, Duh QY, Clark OH: Medullary thyroid carcinoma: Clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer 2000;88:1139-1148.
22. Schuffenecker I, Virally-Monod M, Brohet R, Goldgar D, Conte-Devolx B, Leclerc L, Chabre O, Boneu A, Caron J, Houdent C, Modigliani E, Rohmer V, Schlumberger M, Eng C, Guillausseau PJ, Lenoir GM: Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. Groupe D'etude des Tumeurs a Calcitonine. J Clin Endocrinol Metab 1998;83:487-491.
23. Carlson KM, Dou S, Chi D, Scavarda N, Toshima K, Jackson CE, Wells SA Jr, Goodfellow PJ, Donis-Keller H: Single missense mutation in the tyrosine kinase catalytic domain of the RET rotooncogene is associated with MEN2B. Proc Natl Acad Sci USA, 1994;91:1579.
24. Wells SA Jr; Franz C: Medullary carcinoma of the thyroid gland. World J Surg 2000,24:952-956.
25. Marsh DJ, Coulon V, Lunetta KL, Rocca-Serra P, Dahia PL, Zheng Z, Liaw D, Caron S, Duboue B, Lin AY, Richardson AL, Bonnetblanc JM, Bressieux JM, Cabarrot-Moreau A, Chompret A, Demange L, Eeles RA, Yahanda AM, Fearon ER, Fricker JP, Gorlin R J: Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum Mol Genet 1998;7:507-515.
26. Eng C: The role of PTEN, a phosphatase gene, in inherited and sporadic nonmedullary thyroid tumors. Rec Prog Horm Res 1999;54:441-452. Discussion, 453.
27. Talpos GB: In: Clark OH, Duh QY (eds): Textbook of Endocrine Surgery. Non-Multiple Endocrine Neoplasia Endocrine Syndromes. 1997, pp 635-641.
28. Goto M, Miller RW, Ishikawa Y, Sugano H: Excess of rare cancers in Werner syndrome (adult progeria). Cancer Epidemiol Biomark Prevent 1996;5:239-246.
29. Ishikawa Y, Sugano H, Matsumoto T, Furuichi Y, Miller RW, Goto M: Unusual features of thyroid carcinomas in Japanese patients with Werner syndrome and possible genotype-phenotype relations to cell type and race (see comments). Cancer 1999;85:1345-1352.
30. Nehlin JO, Skovgaard GL, Bohr VA: The Werner syndrome. A model for the study of human aging. Ann N Y Acad Sci 2000;908:167-179.
31. Huang SM, Duh QY, Shaver J, Siperstein AE, Kraimps JL, Clark OH: Familial hyperparathyroidism without multiple endocrine neoplasia. World J Surg 1997;21:22-28.
32. Kraimps JL, Duh QY, Demeure M, Clark OH: Hyperparathyroidism in multiple endocrine neoplasia syndrome. World J Surg 1992;112:1080-1085.
33. van de Graaf SA, Ris-Stalpers C, Veenboer GJ, Cammenga M: A premature stopcodon in thyroglobulin messenger RNA results in familial goiter and moderate hypothyroidism. J Clin Endocrinol Metab 1999;84:2537-2542.
34. Kraimps JL, Canzian, F, Jost C, Menet E, Amati P, Levillian P, Harach R, Lesueur F, Barbier J, Romeo G, Bonneau D: Mapping of a gene disposing to familial thyroid tumors with cell oxyphilia to chromosome 19 and exclusion of JUN 8 as a candidate gene. Surgery 1999;126:1188-1194.
35. Bignell GR, Canzian F, Shayeghi M, Stark M, Shugart YY, Biggs P, Mangion J, Hamoudi R, Rosenblatt J, Buu P, Sun S, Stoffer SS, Goldgar DE, Romeo G, Houlston RS, Narod SA, Stratton MR, Foulkes WD: Familial nontoxic multinodular goiter locus maps to chromosome 14q, but does not account for familial nonmedullary thyroid cancer. Am J Hum Genet 1997;61:1123-1130.
36. Dackiw A, Kuerer H, Clark OH: Current health care insurance policy for prophylactic thyroidectomy. (IAES 2001) World J Surg 2002;26:903-906.
37. Delbridge L, Robinson B: Genetic and biochemical screening for endocrine disease: III. Cost and logistics. World J Surg 1998,22:1212-1217.
38. Robinson D, Orr T: Carcinoma of the thyroid and other diseases of the thyroid in identical twins. Arch Surg 1955;70:923-928.
39. Smith W: Familial multiple polyposis: research tool for investigating the etiology of carcinoma of the colon? Dis Col Rect 1968;11:17-31.
40. Ron E, Kleinerman RA, LiVolsi VA, Fraumeni JF Jr: Familial nonmedullary thyroid cancer. Oncology 1991;48:309-311.
41. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH: J National Cancer Institute 1994;86:1600-1608.
42. Imrie H, Vaidya B, Perros P, Kelley WF, Toft AD, Young ET, Kendall-Taylor P, Pearce SHS: Evidence for a Graves' disease susceptibility locus at chromosome Xpll in a United Kingdom population. J Clin Endocrinol Metab 2001;86:626-630.
43. Pearce SHS, Vaidya B, Imrie, Perros P, Kelly WF, Toft AD, McCarthy MI, Young ET, Kendall-Taylor P: Further evidence for a susceptibility locus on chromosome 20q13.11 in families with dominant transmission of Graves' disease. Am J Hum Genet 1999;65:1462-1465.
44. Filetti S; Belfiore A; Amir SM; Daniels GH; Ippolito O; Vigneri R; Ingbar SH: The role of thyroid-stimulating antibodies of Graves' disease in differentiated thyroid cancer. N Engl J Med 1988,318:753-759.
45. Alsanea O, Clark OH: Familial thyroid cancer. Curr Opin Oncol 2001;13:4451.
46. Baiter M: Children become the first victims of fallout (news). Science 1996;272:357-360.
47. Cetta F; Gori M; Raffaelli N; Baldi C; Montalto G: Comment on clinical and prognostic relevance of Ret-PTC activation in patients with papillary thyroid carcinoma (letter; comment). J Clin Endocrinol Metab 1999;84:2257-2258.
48. Cetta F, Olschwang S, Petracci M, Montalto G, Baldi C, Zuckermann M, Costantini RM, Fusco A: Genetic alterations in thyroid carcinoma associated with familial adenomatous polyposis: clinical implications and suggestions for early detection. World J Surg 1998;22:1231-1236.
49. Perkel VS, Gail MH, Lubin J, Pee DY, Weinstein R, Shore-Freedman E, Schneider AB: Radiation-induced thyroid neoplasms (evidence for familial susceptibility factors. J Clin Endocrinol Metab 1988;66:1316-1322.
50. Miller AR, McBride WH, Hunt K, Economou JS: Cytokine-mediated gene therapy for cancer. Ann Surg Oncol 1994;1:436-450.
51. Kikuchi S, Perrier N, Siperstein AE: Evaluation of Fine Needle Aspiration in Patients with Radiation Induced Thyroid Neoplasm. Presented ATA 1999, October.
52. Grossman RF, Tu SH, Duh QY, Siperstein AE, Novosolov F, Clark OH: Familial non medullary thyroid cancer: An emerging entity that warrants aggressive treatment. Arch Surg 1995,13:892-897.
53. Lupoli G, Vitale G, Caraglia M, Fittipaldi MR, Abruzzese A, Tagliaferro P, Bianco AR: Familial papillary thyroid microcarcinoma: a new clinical entity. Lancet 1999;353:637-639.
54. Osaki D, Ito K, Kobayashi K, Suzuki A, Manabe Y, Hosoda Y: Familial occurrence of differentiated non medullary thyroid carcinoma. World J Surg 1988: 12:565-571.
55. Takami H, Ozaki O, Ito K: Familial non medullary thyroid cancer: An emerging entity that warrants aggressive treatment. Arch Surg 1996,131:676.
56. Loh KC, Lo JC, Greenspan FS, Miller TR, Yeo PP: Familial papillary thyroid cancer: A case report. Ann Acad Med Singapore 1997,26:503-506.